BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...is linked to the α-emitting cytotoxic isotope actinium-225. Fusion’s shareholders include HealthCap, Adams Street Partners, Varian Medical Systems...
BioCentury | Jun 4, 2020
Management Tracks

Giroir stepping down as COVID-19 testing czar; plus Gilead, Sanofi Ventures, Varian, Sirtex and Oxford BioMedica

...NASDAQ:SNY) in April as head of investments; he was a VP at Pivotal bioVenture Partners. Varian Medical Systems Inc....
...and UCB S.A. (Euronext:UCB). Robin Sawka, BioCentury Staff U.S. Department of Health and Human Services Gilead Sciences Inc. Sanofi Ventures Sanofi Varian Medical Systems Inc. Sirtex...
BioCentury | Sep 16, 2019
Company News

Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian

...million capital commitment (see "Foghorn Launches with $50M for Chromatin Remodeling Platform" ). Cancer company Varian Medical Systems Inc....
...of medical affairs for BTG Plc., which was acquired by Boston Scientific (NYSE:BSX). BioCentury Staff Foghorn Therapeutics Inc. Varian Medical Systems Inc. FasterCures Milken...
BioCentury | Sep 14, 2018
Financial News

Epic raises $52M series E

...series E round led by Blue Ox Healthcare Partners. Fellow new investors Deerfield Management and Varian Medical Systems Inc....
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Capital, HealthCap, Johnson & Johnson Innovation - JJDC Inc., Seroba Life Sciences, TPG Biotech and Varian Medical Systems Inc....
BioCentury | Sep 29, 2017
Financial News

Fusion, IsoPlexis, Tempus announce venture financings

...bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems...
BioCentury | Sep 25, 2017
Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

...bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems...
BioCentury | Mar 3, 2017
Financial News

Grail completes venture financing

...Co. , Celgene Corp. , McKesson Ventures, Merck & Co. Inc. , Tencent Holdings and Varian Medical Systems...
BioCentury | Mar 2, 2017
Financial News

Grail raises $900M toward planned $1B round

...arm of McKesson Corp. (NYSE:MCK), Merck & Co. Inc. (NYSE:MRK), Tencent Holdings Ltd. (HKSE:700) and Varian Medical Systems Inc....
...the company. Jaime De Leon Arch Venture Partners Bristol-Myers Squibb Co. Celgene Corp. Grail Inc. Johnson & Johnson McKesson Corp. Merck & Co. Inc. Varian Medical Systems Inc. Tencent...
BioCentury | Oct 2, 2015
Company News

Management tracks

...Baker was VP of finance for international business at AstraZeneca plc (LSE:AZN; NYSE:AZN). Oncology play Varian Medical Systems Inc....
Items per page:
1 - 10 of 17
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...is linked to the α-emitting cytotoxic isotope actinium-225. Fusion’s shareholders include HealthCap, Adams Street Partners, Varian Medical Systems...
BioCentury | Jun 4, 2020
Management Tracks

Giroir stepping down as COVID-19 testing czar; plus Gilead, Sanofi Ventures, Varian, Sirtex and Oxford BioMedica

...NASDAQ:SNY) in April as head of investments; he was a VP at Pivotal bioVenture Partners. Varian Medical Systems Inc....
...and UCB S.A. (Euronext:UCB). Robin Sawka, BioCentury Staff U.S. Department of Health and Human Services Gilead Sciences Inc. Sanofi Ventures Sanofi Varian Medical Systems Inc. Sirtex...
BioCentury | Sep 16, 2019
Company News

Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian

...million capital commitment (see "Foghorn Launches with $50M for Chromatin Remodeling Platform" ). Cancer company Varian Medical Systems Inc....
...of medical affairs for BTG Plc., which was acquired by Boston Scientific (NYSE:BSX). BioCentury Staff Foghorn Therapeutics Inc. Varian Medical Systems Inc. FasterCures Milken...
BioCentury | Sep 14, 2018
Financial News

Epic raises $52M series E

...series E round led by Blue Ox Healthcare Partners. Fellow new investors Deerfield Management and Varian Medical Systems Inc....
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Capital, HealthCap, Johnson & Johnson Innovation - JJDC Inc., Seroba Life Sciences, TPG Biotech and Varian Medical Systems Inc....
BioCentury | Sep 29, 2017
Financial News

Fusion, IsoPlexis, Tempus announce venture financings

...bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems...
BioCentury | Sep 25, 2017
Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

...bringing the total to $46 million. New investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems...
BioCentury | Mar 3, 2017
Financial News

Grail completes venture financing

...Co. , Celgene Corp. , McKesson Ventures, Merck & Co. Inc. , Tencent Holdings and Varian Medical Systems...
BioCentury | Mar 2, 2017
Financial News

Grail raises $900M toward planned $1B round

...arm of McKesson Corp. (NYSE:MCK), Merck & Co. Inc. (NYSE:MRK), Tencent Holdings Ltd. (HKSE:700) and Varian Medical Systems Inc....
...the company. Jaime De Leon Arch Venture Partners Bristol-Myers Squibb Co. Celgene Corp. Grail Inc. Johnson & Johnson McKesson Corp. Merck & Co. Inc. Varian Medical Systems Inc. Tencent...
BioCentury | Oct 2, 2015
Company News

Management tracks

...Baker was VP of finance for international business at AstraZeneca plc (LSE:AZN; NYSE:AZN). Oncology play Varian Medical Systems Inc....
Items per page:
1 - 10 of 17